A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2003

Conditions
HIV Infections
Interventions
DRUG

Kaletra® (lopinavir/ritonavir)

DRUG

Combivir® (lamivudine, zidovudine)

DRUG

Sustiva® (efavirenz)

Trial Locations (1)

92708

Fountain Valley Regional Hospital and Medical Center, Fountain Valley

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY